Back to Authors

Ostapenko, Yurii

A5086299933 | I4210123359

Mayo Clinic

National Cancer Institute

Citations 1

Plain language summary of the HIMALAYA study: tremelimumab and durvalumab for unresectable hepatocellular carcinoma (liver cancer)

Future Oncology | September 6, 2023 | Volume: 19 | Issue: 38 | Pages: 2505-2516

10.2217/fon-2023-0486 | PMID 37671641